CLINICAL INFORMATION
FEATURED DATA FROM OUR CLINICAL STUDIES
Challenging surgery?
Rely on Ogmend® to ensure you’re always prepared to secure stable screw fixation.
Anticipated need based on pre-op assessment
Spontaneous need based on Intra-op condition
Emergency need based on revision or extension
Featured Data
-
![]()
Clinical Data Poster - Spine
AO Global Spine Conference | November 2021
Graphical summary of an evaluation of patients followed for 24-months after treatment with Ogmend®.
-
![]()
Clinical Study Data - Spine
European Spine Journal | October 2020
Evaluation of patients followed for 24-months after treatment with Ogmend® at Nottingham University Hospitals, Queens Medical Centre.
-
![]()
Animal Study Data - Metatarsal Fracture Model
VCOT | February 2020
Preclinical assessment of the effectiveness of Ogmend® in a trauma scenario.
-
![]()
Animal Study Data - Lumbar Fusion Model
The Spine Journal | December 2018
Preclinical assessment of the effectiveness of Ogmend® in a spine scenario.
-
![]()
Challenges in Fracture Fixation
By Sabine Goldhahn MD | December 2014
AO Whitepaper regarding fracture fixation and what types of factors influence success.
indications for use
-
Ogmend® Spine & Trauma Systems
The Ogmend® Implant Enhancement System has 510k Clearance for use with Spine fixation systems and Long Bone Trauma fixation systems (510k De Novo) which allows the systems to be commercialized in the USA.
-
Ogmend® Spine System
The Ogmend® Implant Enhancement System has a CE Certification Mark for use with Spine fixation systems which allows the system to be commercialized in countries that recognize the CE Mark.
Want to request a training or demo?
Please let us know!
We’d be happy to answer your questions regarding FDA or CE cleared use, clinical questions, or any information about Woven Orthopedics and our Ogmend product. Please use the form to reach out to us and we’ll contact as soon as possible.
Thank you for your interest in Woven Orthopedics.